Locke Lord filed a patent infringement lawsuit Monday in New Jersey District Court on behalf of Curia IP Holdings. The complaint targets Salix Pharmaceuticals and other defendants over their antibiotic Xifaxan, which Curia contends contains its patented mixture rifaximin. Counsel have not yet appeared for the defendants. The case is 2:21-cv-19293, Curia IP Holdings, LLC v. Salix Pharmaceuticals Ltd. et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector. 

Read the document here: